Blood from seven newborns, a 13-y-old, and seven adult family members with a suspected hemoglobinopathy because of unexplained cyanosis was obtained for analysis to determine Hb oxygen affinity and to characterize and quantify the Hb variants. Their oxygen saturation was 76 to 84%. The P 50 was 30.3 Ϯ 2.9 for the newborns and 32.5 Ϯ 2.6 mm Hg for their related adults. In the same order, the plasma erythropoietin was 7.4 Ϯ 2.9 and 15.9 Ϯ 3.7 mU/mL, whereas 2,3-diphosphoglycerate was 16.1. Ϯ 2.9 and 15.9 Ϯ 3.7 mol/g Hb. In four of the newborns with increased P 50 , the mother had a normal P 50 (27 mm Hg), which indicated a greater maternal oxygen affinity than the fetus with no adverse effects on the fetus. Genetic analysis of ␣-globin genes demonstrated a heterozygous mutation on the ␣2 gene [␣94(G1)Asp3 His] for each of the newborns and their related adults. The same mutation was found on the ␣1 gene in an adolescent and her father. The mRNA measurements showed that the ␣2-to ␣1-globin mRNA mean ratio was 2.5, ␣2 mutant globin mRNA/total ␣2-globin mRNA was 45.0%, whereas the ␣1 mutant globin mRNA/total ␣1-globin mRNA was 37.8%. The level of ␣2 mutant globin/total ␣-globin was 27.3 Ϯ 1%, and ␣1 mutant globin/total ␣-globin was 23.8 Ϯ 1%. The percentage of synthesized ␣2 and ␣1 mutant globins was 27.5 Ϯ 2 and 26.1 Ϯ 1, respectively. The ratio of the ␣2/␣1 mutant globins was 1.1, which corresponded to a ratio at the mRNA level of ␣2/␣1 of 2.5 Ϯ 0.5, which suggested that there is a less efficient translation of the ␣2 mRNA than ␣1 mRNA. The reversal of the physiologic fetomaternal oxygen affinity had no effects on fetal development. Abbreviations ODC, Hb-oxygen dissociation curve DPG, 2,3-diphosphoglycerate P 50 , PO 2 required to achieve a saturation of 50% at pH 7.4 and 37°C
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A rare mutant Hb with a low oxygen affinity designated as Sunshine Seth [␣94(G 1 ) Asp3 His] (1) was detected in a series of newborn infants as well as in a 13-y-old and her father. The infants, because of persistent cyanosis, were transferred soon after birth to a neonatal intensive care unit to investigate the cause of their Hb desaturation. The cyanotic infants and their parents provided an opportunity to evaluate the physiologic implications of low oxygen Hb affinity during the perinatal period as well as carry out genetic analysis to further the knowledge of the of human ␣-globin gene expression.
The two human ␣-globin genes ␣1 and ␣2 are coexpressed in normal erythroid cells and encode identical ␣-globin protein products. The ␣2 gene encodes a 2-3-fold higher level of mRNA than the ␣1 gene (2) . Because of the identical ␣-globin produced, the relative levels of expression are difficult to determine. Despite some data that suggest posttranscriptional/ translational modifications balancing the amount of protein expressed from these mRNA (3), it is still controversial how the difference in ␣2 and ␣1 mRNA levels are reflected at the protein level (4) . Because of a rare occasion in which an identical mutation in both the ␣1 and ␣2 genes existed in different individuals, the relative rate of mutant protein production from each of the loci can be determined and compared. These values can be used to evaluate the efficiency of the translation of the ␣1 and ␣2 mRNA and to determine the relative contribution of normal ␣1 and ␣2 to the total ␣-globin production.
Blood samples obtained from patients with an Hb oxygen desaturation with a suspected hemoglobinopathy were used to determine their ODC and to measure the effects of Hb desaturation on DPG and erythropoietin levels. The samples were also used to determine their mutant globin chain identification and its quantification and rate of synthesis. Finally, a series of molecular genetic studies such as a selective amplification of ␣1-and ␣2-globin genes for sequencing and/or digestion with specific restriction enzymes were carried out to determine the mutation locations, RNase protection assay to determine the relative amounts of ␣2-and ␣1-globin mRNA, and reverse transcriptase-PCR (RT-PCR)-ApaL I digestion to quantify the relative amounts of ␣2 or ␣1 mutant globin mRNA.
METHODS
During a 5-y period (1994 -1999) , seven newborns from the same region of the province of Quebec were transferred to the neonatal intensive care unit soon after birth because of persistent cyanosis. The infants were born at term with a mean birth weight of 3350 Ϯ 440 g. They were all appropriate for weight for gestational age. Because of unexplained desaturation and the lack of symptoms, a hemoglobinopathy was suspected. Six parents of these infants and one grandparent with cyanosis were also investigated. More recently, a 13-y-old girl and her father were added to this series because of unexplained cyanosis and desaturation detected in a pediatric clinic. The arterial oxygen saturation by pulse oximetry (Ohmeda oximeter) of these infants and their related adults ranged from 76 to 84%.
Blood samples were obtained to determine the P 50 from ODC by use of an ODC Hemox-Analyzer (5). Total globin chain content and the rate of protein synthesis was determined by labeling immature red cells with 3 H-leucine and separation of the globins by HPLC (6); as plasma erythropoietin and red cell DPG concentrations were determined by RIA (7) and an enzymatic method, respectively (8) . Finally, DNA and mRNA analysis was carried out on the samples as described below.
ODC. ODC were obtained using the Hemox-Analyzer (TCS Scientific Corp., New Hope, PA, U.S.A.). Fifty microliters of whole blood was added to 4 mL of buffer (135 mM NaCl, 30 mM TES, 5 mM KCl, and NaOH adjusted to pH 7.4 Ϯ 0.02) (TCS buffer; TCS Scientific Corp.), 10 L of antifoam solution, and 20 L of 20% BSA. Samples were analyzed immediately upon collection from the patient. Nitrogen (100%) was bubbled through the sample at a constant rate that resulted in complete deoxygenation within 20 min, followed by reoxygenation with air for 15 min. The analyzer measured the oxygen tension with a standard Clark O 2 electrode (model 5331 Oxygen Probe; Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A.) and simultaneously calculated the Hb saturation by use of dual-wavelength spectrophotometry. The ODC were recorded during both deoxygenation and reoxygenation. The membrane was deoxygenated and reoxygenated in distilled water for a 12-h period the day before all patient studies. The night before each study day, a sample of fresh adult blood was run as a standardization control.
DNA analysis. Genomic DNA was isolated using a QIA amp kit (Qiagen) from the blood samples of patients who had an ␣-globin variant detected by HPLC. The genomic DNA (0.5 g) was subjected to selective amplification of ␣1 and ␣2 DNA using primers in which the upstream primer is common for both ␣ genes-5ЈCCACCAAGATCTACTTCCCGC3Ј (located in Fig. 1 ). The ␣1-specific downstream primer-5ЈTCAAAGACCACGGGGGTACG3Ј (located in Fig. 1 ) and the ␣2-specific downstream primer-5ЈCTTTATTCAAAGAC-CAGGAAGGG3Ј (located in Figs. 1 and 2) amplified specific fragments of 550 bp each. The reaction mixture (50 L) contained 1X PCR buffer (GIBCO), 25 pmol of primer, 0.2 mM dNTP, 1.5 mM magnesium chloride, 10% DMSO, 5% glycerol, and 1.25 U of Taq polymerase (GIBCO). An initial denaturation for 3 min at 94°C followed by 25 cycles of 94°C for 1 min, 52°C for 1 min, 72°C for 1 min, and a final extension at 72°C for 10 min was done in a Perkin-Elmer thermal cycler. The amplified product was electrophoresed on 2% metaphor agarose. The band containing the PCR fragment was purified from the gel with the Qiaquick gel extraction kit (Qiagen). The ␣1 and ␣2 DNA fragments were sequenced using the Thermo RT-PCR of ␣2-globin mRNA. Top, Lane 1 and 2 represent the undigested and ApaL I-digested product, respectively, for a normal subject; lanes 3 and 4, undigested and ApaL I-digested product, respectively, for a patient with an ␣2-globin mutation. Lane 5 contains pBR322DNA/MscI markers. Bottom, Location of the restriction enzyme sites and primers used in this study.
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Sequenase kit (Amersham Pharmacia Biotech) with the same upstream primer.
To assess the mutation location on ␣1 or ␣2 gene locus, we labeled the DNA fragments by use of the same PCR technique described above by adding 2 ci [␣ 32 P]dCTP (3000Ci/mmol) (Amersham) to the reaction mix. Because the mutation abolishes the normal AvaII site at codon 94 and created a new ApaL I site, we used the respective restriction enzymes to evaluate whether the mutation was present in both ␣ locus and both alleles. The specificity of ␣2 and ␣1 amplification was confirmed using Msc I restriction enzyme (BalI isoschizomer), which recognized a site in ␣1 and not in ␣2. Ten microliters of PCR product was digested separately with 10 U of AvaII (Amersham Pharmacia Biotech), 10 U of ApaL I (New England Biolabs), and 10 U of Msc I (New England Biolabs) for 2 h at 37°C. Fragments were resolved on 5% polyacrylamide gel and visualized on PhosporImager (Molecular Dynamics).
RNA Analysis. Total RNA was isolated using RNeasy blood kit (Qiagen). To determine the ratio of mRNA ␣2/␣1, we used RNase protection assay as previously published (9) . To quantify the relative amounts of normal and mutant mRNA, we used RT-PCR based on published methods (10) . At first, 0.5 g of RNA was reverse transcribed using 0.5 g of oligo dT primer (GIBCO) in 1X PCR buffer (GIBCO), 0.2 mM dNTP, 1.5 mM MgC1 2 , 10 mM DTT, 40 U of RNA guard (Amersham Pharmacia Biotech), with 400 U of M-MLV reverse transcriptase (GIBCO) by incubation at 42°C for 60 min followed by inactivation of reverse transcriptase at 94°C for 5 min. The entire reverse-transcribed sample was then PCR amplified in a 50-L volume containing 25 pmol of common upstream primer-5ЈCGACAAGACCAACGTCAAGG3Ј (located in Fig. 2 ), 25 pmol of the desired ␣-specific downstream primer (described above), and 1.25 U of Taq polymerase (GIBCO). Cycling was 94°C for 1 min, 52°C for 1 min, 72°C for 1 min, for 30 cycles and a final extension at 72°C for 10 min done in a Perkin-Elmer thermal cycler. The upstream primer (800 pmol) was labeled to high specific activity with 5 L of ␥ 32 P-ATP (6000ci/mmol) (Amersham), 30 U of polynucleotide kinase (New England Biolabs), and purified on a Qiaquick nucleotide removal kit (Qiagen). Ten microliters of the amplified products was then radioactively labeled with 32 P end-labeled upstream primer by one cycle of extension. The reaction mixture contained 1X PCR buffer (GIBCO), 0.1 mM dNTP, 1.5 mM MgCl 2 , 40 pmol of labeled primer, and 1.25 U of Taq polymerase (GIBCO) in final volume of 20 L (denaturation for 3 min at 94°C, annealing for 2 min at 52°C, and extension for 10 min at 72°C). Ten microliters of the labeled PCR product was subsequently digested with 10 U of ApaL I (New England Biolabs) for 2 h at 37°C and resolved on a nondenaturing 6% polyacrylamide gel and quantified with PhosphorImager (Molecular Dynamics).
Genotype analysis. The ␣-globin gene arrangement was confirmed by PCR amplification of genomic DNA similarly as described by Molchanova et al. (3) . Briefly, 0.5 g of DNA was amplified for 35 cycles with an upper and downstream primer common for both ␣1 and ␣2, followed by a 5Ј end labeling of the amplified product in a one-cycle PCR. A digestion of the amplified product with the restriction enzyme ApaI, which has a site in ␣1-IVS-II, allowed the separation and quantitation of ␣1 and ␣2 DNA fragments.
The present study was approved by the Institutional Review Board and has been conducted with informed consent.
RESULTS
The P 50 values for the carriers of the ␣2-globin mutant were 30.3 Ϯ 2.9 mm Hg for the newborn infants and 32.5 Ϯ 2.6 for the adults, whereas the mean P 50 was 31.3 Ϯ 0.4 for the adults with ␣1-globin mutant. The plasma erythropoietin and DPG concentrations both in adults and newborns were within normal limits (11) (12) (13) . These results are shown in Table 1 .
An example of the globin chain separation from a newborn infant by HPLC after 3 H-leucine labeling is shown in Figure 3 . The split in the ␣-globin peak identified the mutant ␣-globin. Fetal Hb comprised 84% of the total Hb, whereas synthesis of fetal Hb was 68% of total Hb synthesis. This level of Hb F synthesis was within the normal range of term infants (14) . The mutant ␣-subunit was 28% of the total ␣-subunits. As shown on Table 1 , the mean ␣1 mutant globin of the infants included in this study was 23.8%, whereas its synthesis was 26%. Also, the mean ␣2 mutant globin level was 27% of total ␣-globin, whereas its synthesis was 27% of total ␣ synthesis. Figure 4 illustrates the Hb ODC from a newborn with a low oxygen affinity hemoglobinopathy in comparison with the (12) 27 Ϯ 1 (13) DPG (mol/g Hb) 16.1 Ϯ 2.9 16.0 Ϯ 2.6 13.6 Ϯ 0.8 14.8 Ϯ 2 (12) 15 Ϯ 3 (13) Epo (mU/mL) 7.4 Ϯ 2.9 15.9 Ϯ 3.7 13.9 Ϯ 2.3 8 Ϯ 4 (11) 15 Ϯ 5 (11) (␣2/␣1)-globin mRNA 2.5 Ϯ 0.5 2.4 Ϯ 0.3 2.3 Ϯ 0.1 2.3 Ϯ 0.4 (9) 2.6 Ϯ 0.4 (2) ␣2-mutant globin mRNA/total ␣2-globin mRNA 45.0 Ϯ 3% ␣2-mutant globin synthesis/total ␣-globin synthesis 27.5 Ϯ 2% ␣2-mutant globin/total ␣-globin total 27.3 Ϯ 1% ␣1-mutant globin mRNA/total ␣1-globin mRNA 37.8 Ϯ 2% ␣1-mutant globin synthesis/total ␣-globin synthesis 26.1 Ϯ 1% ␣1-mutant globin/total ␣-globin total 23.8 Ϯ 1%
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THE EXPRESSION OF ␣1-AND ␣2-GLOBIN GENES normal mother as well as a normal control newborn infant. The normal maternal-fetal oxygen gradient is reversed because the mutation is on the ␣-globin, and, therefore, it affects the Hb oxygen affinity during most of fetal development. Four of the infants included in this study were born to mothers without a hemoglobinopathy, which meant that these infants had a reversal of their maternal-fetal gradient during fetal life. There was no evidence of any adverse sequelae in these infants. The results of the sequencing of the regions of the ␣ genes in which the heterozygous mutations occurred are shown in Figure 5 , which demonstrates the normal ␣1 and ␣2 gene as well as the ␣1 and ␣2 mutation in the region of interest. The mutation ␣94 GAC3 CAC results in a replacement of asparagine by histidine. The confirmation of the presence of a heterozygous ␣1 mutation is demonstrated in Figure 1 . Figure  2 illustrates an example of the separation of the products of RT-PCR after ApaL I digestion, which provides the data to determine ␣2 mutant mRNA ratio to total ␣2 mRNA. The ratio of the sample shown in Figure 2 was 44.0%. The mean percentages of ␣2 mutant mRNA in total ␣2 mRNA and ␣1 mutant in total ␣1 mRNA were 45.0 Ϯ 1.3% and 37.8 Ϯ 2%, respectively. The ratio of the ␣2-to ␣1-globin mRNA as determined by RNase protection assay ranged from 2.2 to 2.8.
The mean values of the ratio were similar in the newborns and the adults (as shown in Table 1 ).
The variations in ␣1 and ␣2 mutant mRNA abundance could not be attributed to deviations from normal ␣␣/␣␣ genotype, because simultaneous amplification and quantification of ␣1 and ␣2 gene fragments revealed a ratio of 1.2. Thus, the subjects had a normal genetic complement of ␣␣/␣␣.
The molecular analysis demonstrated a rare heterozygous mutation [␣94(G 1 )Asp3 His] on the ␣2 gene for all of the infants and their related adults except for a 13-y-old and her father in whom the identical mutation was found on the ␣1 gene.
DISCUSSION
The transport of oxygen from mother to fetus is believed to be aided by their differences in oxygen affinity. The ODC of paired fetal-maternal samples from 16 species of mammals have been studied showing that fetal oxygen affinity exceeds that of the maternal, the only exception being the cat in which they are the same (15, 16) . Although nearly all mammals show such a difference, the usual difference in oxygen affinity between adult and fetal Hb has never been shown to be necessary for a healthy fetal development. The infants in this study were all born at term, appropriate in weight for gestational age and without any evidence of hypoxic erythropoietic stress. They are all followed by a pediatrician and are considered to be 72 growing and developing normally. There are numerous cases described in which maternal blood has a higher oxygen affinity without any detrimental effects on the fetus (17) . This difference in oxygen affinity between fetal and adult blood per se may not be an essential requirement for the transfer of oxygen across the placenta.
In this study, a rare mutation [␣94(G1)Asp3 His] in one of the ␣2 alleles in a group of related French Canadian families from the same region of the Province of Quebec, Canada, as well as an identical mutant in one of the ␣1 alleles of a father and daughter of the same ethnic group but unrelated has been studied. The identical mutant could be the result of a gene conversion between duplicated loci or an independent mutation. Normally, when Hb A is oxygenated, ␤102 Asn forms a hydrogen bond with ␣94 Asp. An amino acid substitution at this location that is critical to Hb function prevents the formation of the bond between ␣94 and ␤102 that normally stabilizes oxyhemoglobin. This phenomenon explains the low oxygen affinity mutants such as Hb Kansas (␤102 Asn3 Thr), Hb Beth Israel (␤102 Asn3 Ser), and Hb Titusville (␣94 Asp3 Asn) (18) . The same mechanism is a likely explanation of the low oxygen affinity in the groups of patients of this study with Hb Sunshine Seth (␣94 Asp3 His). The individuals described in this study have no apparent clinical or hematologic abnormalities. Unexplained cyanosis in association with normal arterial oxygen pressure should prompt investigation for an abnormal Hb mutant and may obviate the need for extensive diagnostic procedures.
Although the protein products of the ␣2 and ␣1 genes are identical, methods exploiting the sequence divergence in their noncoding regions have enabled the relative amounts of ␣2 and ␣1 mRNA to be determined. The synthesis of an ␣-globin mutant in a heterozygous individual represents the expression of one of the four ␣-globin genes. The mean percentage of the abnormal globin in the ␣2 mutation was 27.5 Ϯ 1% and the ␣1 mutation 23.8 Ϯ 1%. These values correspond to a ratio of ␣2 mutant to ␣1 mutant of 1.1 to 1 at both the protein and protein synthesis level, whereas the mean ratio of ␣2 and ␣1 mRNA ranged from 2.3 to 2.5. This finding supports the observations of Molchanova et al. (3) showing that mutations at the two ␣-globin loci result in small differences on their effects on ␣-globin synthesis, but does not concord with the work of Liebhaber et al. (4) who carried out in vitro translation studies showing higher output of ␣2-globin gene in both mRNA and protein.
This mutant caused a reversal of the maternal fetal oxygen affinity gradient with no detrimental effects on fetal growth and development. The presence of an identical mutation on either the ␣1-or the ␣2-globin gene in different individuals provided a unique opportunity to substantiate whether there is the existence of a major and minor ␣-globin locus. The observed base change was confirmed by amplification, sequencing, and/or digestion with specific restriction enzymes in samples from subjects with either ␣1 or ␣2 mutant globin. The effect of each of the identical ␣-globin mutants on the lowering Hb oxygen affinity was the same. The mutant ␣1-and ␣2-globin chains comprised close to 25% of the ␣-globin chains in the circulating red cells as well as the newly synthesized mutant ␣-globins in the reticulocytes. (If ␣2-globin were expressed 2.5 times ␣1-globin, the proportion of mutant ␣1-globin chains would be in the 10% range.) There was, thus, a 2.5 higher transcription of ␣2-globin gene compared with the ␣1-globin gene and a 2.5 higher efficiency in the translation of the ␣1-globin gene. The result is an almost equal synthesis of ␣-globin chains by either one of the two genes.
